Low-dose IL-2 treatment in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled trialJ. He, J. Chen,Y. Jin, X. Zhang,R. Zhang,X. Zhang, X. Sun,Z. LiEUROPEAN JOURNAL OF IMMUNOLOGY（2019）引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
